C-Reactive Protein Test Market Size, Share, Trends, Growth Outlook

C-Reactive Protein Test Market is estimated to increase at a growth rate of 5.1% CAGR over the forecast period from 2024 to 2030.

The global C-Reactive Protein Test Market Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Type (Immunoturbidimetric Assay, ELISA, Chemiluminescence Immunoassay, Others), By Detection Range, hS-CRP, Conventional CRP, cCRP), By Disease (Cardiovascular Diseases, Cancer, Rheumatoid Arthritis, Inflammatory Bowel Disease, Endometriosis, Lupus, Others), By End-User (Clinics, Hospitals, Laboratories, Assisted Living Healthcare Facilities, Home, Others).

An Introduction to C-Reactive Protein Test Market in 2024

The C-Reactive Protein Test Market involves diagnostic tests and assays used to measure C-reactive protein (CRP) levels in blood samples, indicating inflammation levels in the body. CRP testing is valuable in assessing cardiovascular risk, monitoring infections, autoimmune diseases, and inflammatory conditions such as rheumatoid arthritis. In 2024, this market addresses high-sensitivity CRP assays, point-of-care testing devices, and CRP testing in personalized medicine for predicting disease progression and guiding therapeutic decisions.

C-Reactive Protein Test Market Competitive Landscape

The global C-Reactive Protein Test Industry is highly competitive with a large number of companies focusing on niche market segments. Amidst intense competitive conditions, C-Reactive Protein Test Companies are investing in new product launches and strengthening distribution channels. Key companies operating in the C-Reactive Protein Test Industry include- Abbott Laboratories, Aidian, Boditech Med Inc, Danaher Corp, F. Hoffmann-La Roche Ltd, Getein Biotech Inc, HORIBA Ltd, Merck KGaAA, Ortho Clinical Diagnostics, Quest Diagnostics, Randox Laboratories Ltd, Siemens Healthineers AG, Thermo Fisher Scientific Inc, Zoetis.

C Reactive Protein Test Market Trend: Shift towards Personalized Medicine and Biomarker Testing

A prominent trend in the C Reactive Protein Test market is the shift towards personalized medicine and the increasing use of biomarker testing in healthcare. With advancements in molecular diagnostics and precision medicine, there's a growing emphasis on tailoring medical treatments to individual patient characteristics, including their genetic makeup, disease profile, and biomarker status. C Reactive Protein (CRP) testing plays a crucial role in this paradigm shift by providing valuable information about inflammation levels in the body, which can aid in disease diagnosis, prognosis, and treatment monitoring. As healthcare providers and patients alike recognize the importance of personalized approaches to healthcare, the demand for CRP testing is expected to rise, driving market growth.

C Reactive Protein Test Market Driver: Rising Prevalence of Inflammatory Conditions and Chronic Diseases

A significant driver for the C Reactive Protein Test market is the increasing prevalence of inflammatory conditions and chronic diseases globally. Inflammation is a key component of many diseases, including cardiovascular diseases, autoimmune disorders, infections, and certain types of cancer. As the incidence of these conditions continues to rise due to factors such as aging populations, unhealthy lifestyles, and environmental factors, there is a growing need for reliable and cost-effective biomarker tests like CRP testing for early detection, disease monitoring, and risk stratification. The rising burden of chronic inflammatory diseases drives demand for CRP testing in various healthcare settings, including hospitals, clinics, and diagnostic laboratories.

C Reactive Protein Test Market Opportunity: Expansion into Point-of-Care Testing and Home Healthcare Settings

An opportunity for market expansion in the C Reactive Protein Test market lies in the expansion into point-of-care testing (POCT) and home healthcare settings. With the growing emphasis on timely diagnosis, rapid results, and patient convenience, there's a shift towards decentralized testing platforms that enable CRP testing to be performed outside traditional laboratory settings. POCT devices and home CRP testing kits offer the advantages of faster turnaround times, reduced healthcare costs, and improved patient satisfaction. By developing user-friendly and reliable POCT devices and home testing kits for CRP measurement, manufacturers can tap into new market segments, including primary care clinics, emergency departments, and home healthcare providers, and address unmet needs in decentralized testing and remote monitoring of inflammatory conditions.

Market Share Analysis: Chemiluminescence Immunoassay for C Reactive Protein Test is the fastest growing segment in the C Reactive Protein Test industry

Within the C Reactive Protein (CRP) Test market, the Chemiluminescence Immunoassay segment stands out as the fastest-growing category. Chemiluminescence immunoassay is a highly sensitive and specific technique used for the quantitative measurement of CRP levels in blood samples. This method offers several advantages, including rapid results, high accuracy, and wide detection range. As CRP is a key biomarker for assessing inflammation in various diseases such as cardiovascular diseases, cancer, rheumatoid arthritis, and inflammatory bowel disease, the demand for accurate and reliable CRP testing methods is increasing. Additionally, the Chemiluminescence Immunoassay technique enables the detection of different forms of CRP, including high-sensitivity CRP (hS-CRP) and conventional CRP (cCRP), catering to the diverse diagnostic needs of healthcare providers. Clinics, hospitals, laboratories, and assisted living healthcare facilities are among the key end-users driving the adoption of Chemiluminescence Immunoassay for CRP testing due to its efficiency and effectiveness in diagnosing and monitoring various inflammatory conditions. As a result, this segment is witnessing rapid growth within the CRP test market.

C-Reactive Protein Test Market Segmentation

By Type
Immunoturbidimetric Assay
ELISA
-Clinical
-Nonclinical
Chemiluminescence Immunoassay
Others
By Detection Range
hS-CRP
Conventional CRP
cCRP
By Disease Area
Cardiovascular Diseases
Cancer
Rheumatoid Arthritis
Inflammatory Bowel Disease
Endometriosis
Lupus
Others
By End-User
Clinics
Hospitals
Laboratories
Assisted Living Healthcare Facilities
Home
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

C-Reactive Protein Test Companies

Abbott Laboratories
Aidian
Boditech Med Inc
Danaher Corp
F. Hoffmann-La Roche Ltd
Getein Biotech Inc
HORIBA Ltd
Merck KGaAA
Ortho Clinical Diagnostics
Quest Diagnostics
Randox Laboratories Ltd
Siemens Healthineers AG
Thermo Fisher Scientific Inc
Zoetis
* List not Exhaustive

Reasons to Buy the C-Reactive Protein Test Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the C-Reactive Protein Test Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the C-Reactive Protein Test Industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 C-Reactive Protein Test Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global C-Reactive Protein Test Market Size Outlook, $ Million, 2021 to 2030
3.2 C-Reactive Protein Test Market Outlook by Type, $ Million, 2021 to 2030
3.3 C-Reactive Protein Test Market Outlook by Product, $ Million, 2021 to 2030
3.4 C-Reactive Protein Test Market Outlook by Application, $ Million, 2021 to 2030
3.5 C-Reactive Protein Test Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of C-Reactive Protein Test Industry
4.2 Key Market Trends in C-Reactive Protein Test Industry
4.3 Potential Opportunities in C-Reactive Protein Test Industry
4.4 Key Challenges in C-Reactive Protein Test Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global C-Reactive Protein Test Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global C-Reactive Protein Test Market Outlook by Segments
7.1 C-Reactive Protein Test Market Outlook by Segments, $ Million, 2021- 2030
By Type
Immunoturbidimetric Assay
ELISA
-Clinical
-Nonclinical
Chemiluminescence Immunoassay
Others
By Detection Range
hS-CRP
Conventional CRP
cCRP
By Disease Area
Cardiovascular Diseases
Cancer
Rheumatoid Arthritis
Inflammatory Bowel Disease
Endometriosis
Lupus
Others
By End-User
Clinics
Hospitals
Laboratories
Assisted Living Healthcare Facilities
Home
Others
8 North America C-Reactive Protein Test Market Analysis and Outlook To 2030
8.1 Introduction to North America C-Reactive Protein Test Markets in 2024
8.2 North America C-Reactive Protein Test Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America C-Reactive Protein Test Market size Outlook by Segments, 2021-2030
By Type
Immunoturbidimetric Assay
ELISA
-Clinical
-Nonclinical
Chemiluminescence Immunoassay
Others
By Detection Range
hS-CRP
Conventional CRP
cCRP
By Disease Area
Cardiovascular Diseases
Cancer
Rheumatoid Arthritis
Inflammatory Bowel Disease
Endometriosis
Lupus
Others
By End-User
Clinics
Hospitals
Laboratories
Assisted Living Healthcare Facilities
Home
Others
9 Europe C-Reactive Protein Test Market Analysis and Outlook To 2030
9.1 Introduction to Europe C-Reactive Protein Test Markets in 2024
9.2 Europe C-Reactive Protein Test Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe C-Reactive Protein Test Market Size Outlook by Segments, 2021-2030
By Type
Immunoturbidimetric Assay
ELISA
-Clinical
-Nonclinical
Chemiluminescence Immunoassay
Others
By Detection Range
hS-CRP
Conventional CRP
cCRP
By Disease Area
Cardiovascular Diseases
Cancer
Rheumatoid Arthritis
Inflammatory Bowel Disease
Endometriosis
Lupus
Others
By End-User
Clinics
Hospitals
Laboratories
Assisted Living Healthcare Facilities
Home
Others
10 Asia Pacific C-Reactive Protein Test Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific C-Reactive Protein Test Markets in 2024
10.2 Asia Pacific C-Reactive Protein Test Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific C-Reactive Protein Test Market size Outlook by Segments, 2021-2030
By Type
Immunoturbidimetric Assay
ELISA
-Clinical
-Nonclinical
Chemiluminescence Immunoassay
Others
By Detection Range
hS-CRP
Conventional CRP
cCRP
By Disease Area
Cardiovascular Diseases
Cancer
Rheumatoid Arthritis
Inflammatory Bowel Disease
Endometriosis
Lupus
Others
By End-User
Clinics
Hospitals
Laboratories
Assisted Living Healthcare Facilities
Home
Others
11 South America C-Reactive Protein Test Market Analysis and Outlook To 2030
11.1 Introduction to South America C-Reactive Protein Test Markets in 2024
11.2 South America C-Reactive Protein Test Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America C-Reactive Protein Test Market size Outlook by Segments, 2021-2030
By Type
Immunoturbidimetric Assay
ELISA
-Clinical
-Nonclinical
Chemiluminescence Immunoassay
Others
By Detection Range
hS-CRP
Conventional CRP
cCRP
By Disease Area
Cardiovascular Diseases
Cancer
Rheumatoid Arthritis
Inflammatory Bowel Disease
Endometriosis
Lupus
Others
By End-User
Clinics
Hospitals
Laboratories
Assisted Living Healthcare Facilities
Home
Others
12 Middle East and Africa C-Reactive Protein Test Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa C-Reactive Protein Test Markets in 2024
12.2 Middle East and Africa C-Reactive Protein Test Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa C-Reactive Protein Test Market size Outlook by Segments, 2021-2030
By Type
Immunoturbidimetric Assay
ELISA
-Clinical
-Nonclinical
Chemiluminescence Immunoassay
Others
By Detection Range
hS-CRP
Conventional CRP
cCRP
By Disease Area
Cardiovascular Diseases
Cancer
Rheumatoid Arthritis
Inflammatory Bowel Disease
Endometriosis
Lupus
Others
By End-User
Clinics
Hospitals
Laboratories
Assisted Living Healthcare Facilities
Home
Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Abbott Laboratories
Aidian
Boditech Med Inc
Danaher Corp
F. Hoffmann-La Roche Ltd
Getein Biotech Inc
HORIBA Ltd
Merck KGaAA
Ortho Clinical Diagnostics
Quest Diagnostics
Randox Laboratories Ltd
Siemens Healthineers AG
Thermo Fisher Scientific Inc
Zoetis
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Type
Immunoturbidimetric Assay
ELISA
-Clinical
-Nonclinical
Chemiluminescence Immunoassay
Others
By Detection Range
hS-CRP
Conventional CRP
cCRP
By Disease Area
Cardiovascular Diseases
Cancer
Rheumatoid Arthritis
Inflammatory Bowel Disease
Endometriosis
Lupus
Others
By End-User
Clinics
Hospitals
Laboratories
Assisted Living Healthcare Facilities
Home
Others